OFW logo
1-202-933-5394
MENU

Cannabis

DOJ Finalizes Move to Schedule III for Certain Marijuana Products

Cannabis /

The U.S. Department of Justice (DOJ), through the Drug Enforcement Administration (DEA), issued a final order partially rescheduling marijuana under federal law, effective April 22, 2026. While many headlines are framing this as “marijuana being moved to Schedule III,” the reality is more precise and limited—and reflects a phased approach closely tied to last year’s […]

DOJ Finalizes Move to Schedule III for Certain Marijuana Products Read More »

President Trump’s Executive Order (EO), “Increasing Medical Marijuana And Cannabidiol Research,” May Benefit The Cannabis Industry, But Alone, Does Not Reschedule Marijuana

Cannabis /

Today, President Trump signed an Executive Order (EO), Increasing Medical Marijuana and Cannabidiol Research.  While the EO is being widely hailed as a significant advancement in marijuana legalization, in fact, the EO is extremely limited as to marijuana and has no independent legal effect at all on rescheduling marijuana. The EO does represent a potentially

President Trump’s Executive Order (EO), “Increasing Medical Marijuana And Cannabidiol Research,” May Benefit The Cannabis Industry, But Alone, Does Not Reschedule Marijuana Read More »

CANNASWEEP

Cannabis /

August 2024 OFW’s Cannabis Team regularly monitors cannabis news, legislation, regulation, and policy. Our monthly CannaSweep publication summarizes this coverage to keep our clients up-to-date on the latest developments impacting their business. Contact Ben Dash about our Congressional Bill Tracker for monthly tracking of cannabis-related legislation introduced in the U.S. Congress. Please contact us if you have

CANNASWEEP Read More »

FDA and FTC Issue Warning Letters to Companies Selling Copycat Delta-8 THC Food Products

Cannabis, Uncategorized /

On July 16, 2024, the U.S. Food and Drug Administration (FDA) and the Federal Trade Commission (FTC) issued warning letters to six companies for illegally selling copycat food products containing delta-8 tetrahydrocannabinol (THC) and introducing them into the marketplace, violating the Federal Food, Drug, and Cosmetic (FD&C) Act. The FDA highlighted two primary concerns: the

FDA and FTC Issue Warning Letters to Companies Selling Copycat Delta-8 THC Food Products Read More »

Cannabis Administration and Opportunity Act (CAOA) Reintroduced Following Rescheduling Announcement

Cannabis /

On May 1, 2024, Majority Leader Chuck Schumer (D-NY), Senate Finance Committee Chairman Ron Wyden (D-OR), and Senator Cory Booker (D-N.J.)  reintroduced the Cannabis Administration Opportunity Act (text available here). The reintroduction follows the news last week that the Drug Enforcement Administration (DEA) had begun the formal rulemaking process to move marijuana from Schedule I

Cannabis Administration and Opportunity Act (CAOA) Reintroduced Following Rescheduling Announcement Read More »

CANNASWEEP

Uncategorized, Cannabis /

WEEK OF APRIL 5, 2024 OFW’s Cannabis Team regularly monitors cannabis news, legislation, regulation, and policy so our clients stay up-to-date on the latest developments impacting their business. If you have any questions or would like more information about any of the items below, please contact us. We also track cannabis-related legislation introduced in the U.S. Congress. 

CANNASWEEP Read More »

CANNASWEEP 

Cannabis /

WEEK OF March 8, 2024  OFW’s Cannabis Team regularly monitors cannabis news, legislation, regulation, and policy so our clients stay up-to-date on the latest developments impacting their business.  If you have any questions or would like more information about any of the items below, please contact us.  We also track cannabis-related legislation introduced in the U.S. Congress. 

CANNASWEEP  Read More »

Industries

Food & Agriculture
Medical Products
Customs and Trade
Consumer and Commercial Litigation
Government Relations

Our Firm

Home
People
Alumni
About
Contact

Insights

News & Insights
Blog
Facebook Twitter Linkedin